Tempest Therapeutics Insider Trades
NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $1.00M
- Sales
- 0 · $0
- Shares bought / sold
- 462.96K / 0
- Net activity
- Net buying $1.0 million
Tempest Therapeutics insider activity
Over the last 12 months, Tempest Therapeutics insiders reported 2 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $1.0 million and sold $0 worth of stock, for net insider buying of $1.0 million. The most recent filing shows Angel Matthew (CEO and President) buying 231,482 shares at $2.16 on Mar 24, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TPST's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TPST insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 24, 2026 | Angel MatthewCEO and President | Buy | 231,482 | $500.00K | Form 4 |
| Mar 24, 2026 | Angel MatthewCEO and President | Buy | 231,482 | $500.00K | Form 4 |
| Aug 12, 2024 | Versant Venture Capital VI, L.P. & Versant Ventures VI GP, L.P. & Versant Ventures VI GP-GP, LLC & Versant Vantage II, L.P. & Versant Vantage II GP, L.P. & Versant Vantage II GP-GP, LLC & Versant Ventures IV, LLC & Versant Venture Capital IV, L.P. & Versant Side Fund IV, L.P.10% Owner | Sale | 387,999 | $426.99K | Form 4 |
| Aug 8, 2024 | Versant Venture Capital VI, L.P. & Versant Ventures VI GP, L.P. & Versant Ventures VI GP-GP, LLC & Versant Vantage II, L.P. & Versant Vantage II GP, L.P. & Versant Vantage II GP-GP, LLC & Versant Ventures IV, LLC & Versant Venture Capital IV, L.P. & Versant Side Fund IV, L.P.10% Owner | Sale | 400,000 | $540.04K | Form 4 |
| Jul 3, 2024 | Brady Stephen RPresident and CEO | Buy | 35,000 | $73.85K | Form 4 |
| Jul 2, 2024 | Whiting SamuelChief Medical Officer | Buy | 4,672 | $9.95K | Form 4 |
| Jun 28, 2024 | Trojanowski JustinCorporate Controller | Buy | 7,500 | $16.20K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4